Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA

CONCLUSIONS: Plasma EGFRm analysis as early as 3 weeks on-treatment has the potential to predict outcomes in EGFRm advanced NSCLC.PMID:37379430 | DOI:10.1158/1078-0432.CCR-22-3146

Source: Clinical Cancer Research - June 28, 2023 Category: Cancer & Oncology Authors: Jhanelle E Gray Myung-Ju Ahn Geoffrey R Oxnard Frances A Shepherd Fumio Imamura Ying Cheng Isamu Okamoto Byoung Chul Cho Meng-Chih Lin Yi-Long Wu Margarita Majem Oliver Gautschi Michael Boyer Krishna C Bulusu Aleksandra Markovets J Carl Barrett Rachel Hod Source Type: research